Brian M. Ross
Cited by
Cited by
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
BM Ross, J Seguin, LE Sieswerda
Lipids in health and disease 6 (1), 1-19, 2007
One type of gamma-turn, rather than the other gives rise to chain-reversal in proteins
EJ Milner-White, BM Ross, R Ismail, K Belhadj-Mostefa, R Poet
Journal of molecular biology 204 (3), 777-782, 1988
Increased phospholipid breakdown in schizophrenia: evidence for the involvement of a calcium-independent phospholipase A2
BM Ross, C Hudson, J Erlich, JJ Warsh, SJ Kish
Archives of general psychiatry 54 (5), 487-494, 1997
Diagnosis of deep-vein thrombosis: comparison of clinical evaluation, ultrasound, plethysmography, and venoscan with X-ray venogram
DA Sandler, JS Duncan, P Ward, AC Lamont, S Sherriff, JF Martin, ...
The Lancet 324 (8405), 716-719, 1984
Compositions and methods for preparation of poorly water soluble drugs with increased stability
T De, NP Desai, A Yang, Z Yim, P Soon-Shiong
US Patent 8,034,765, 2011
Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia
BM Ross, S Turenne, A Moszczynska, JJ Warsh, SJ Kish
Brain research 821 (2), 407-413, 1999
Phospholipid‐Metabolizing Enzymes in Alzheimer's Disease: Increased Lysophospholipid Acyltransferase Activity and Decreased Phospholipase A2 Activity
BM Ross, A Moszczynska, J Erlich, SJ Kish
Journal of neurochemistry 70 (2), 786-793, 1998
Calcium-independent phospholipase A2 and schizophrenia
NR Smalheiser, DR Swanson
Archives of General Psychiatry 55 (8), 752-753, 1998
Omega-3 polyunsaturated fatty acids and anxiety disorders
BM Ross
Prostaglandins, Leukotrienes and Essential Fatty Acids 81 (5-6), 309-312, 2009
Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder
BM Ross, I McKenzie, I Glen, CPW Bennett
Nutritional neuroscience 6 (5), 277-281, 2003
Phospholipid biosynthetic enzymes in human brain
BM Ross, A Moszczynska, JK Blusztajn, A Sherwin, A Lozano, SJ Kish
Lipids 32 (4), 351-358, 1997
Robustness of G proteins in Alzheimer's disease: an immunoblot study
M McLaughlin, BM Ross, G Milligan, J McCulloch, JT Knowler
Journal of Neurochemistry 57 (1), 9-14, 1991
On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease
BM Ross, JT Knowler, J McCulloch
Journal of neurochemistry 58 (5), 1810-1819, 1992
Hydrogen sulfide and asthma
P Wang, G Zhang, T Wondimu, B Ross, R Wang
Experimental physiology 96 (9), 847-852, 2011
Biomarkers of oxidative stress in schizophrenic and control subjects
J Young, SB McKinney, BM Ross, KWJ Wahle, SP Boyle
Prostaglandins, leukotrienes and essential fatty acids 76 (2), 73-85, 2007
ω− 3 Fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism
BM Ross
Medical hypotheses 68 (3), 515-524, 2007
Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease
BM Ross, N Mamalias, A Moszczynska, AH Rajput, SJ Kish
Neuroscience 102 (4), 899-904, 2001
Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia
C Hudson, A Gotowiec, M Seeman, J Warsh, BM Ross
Biological Psychiatry 46 (3), 401-405, 1999
Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders
SJ Kish, I Lopes-Cendes, M Guttman, Y Furukawa, M Pandolfo, ...
Archives of neurology 55 (10), 1299-1304, 1998
Characterization of a Novel Phospholipase A2 Activity in Human Brain
BM Ross, DK Kim, JV Bonventre, SJ Kish
Journal of neurochemistry 64 (5), 2213-2221, 1995
The system can't perform the operation now. Try again later.
Articles 1–20